SCHEMBL4926993

SCHEMBL4926993

COc1ccccc1Nc1nc(C)c(C(=O)NCc2cccc(OC(F)(F)F)c2)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
MAPT P10636 2/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
KMT2A Q03164 1/20 0.55
MAPK14 Q16539 1/20 0.50
MMP13 P45452 2/20 0.49
ROCK1 Q13464 3/20 0.48
ROCK2 O75116 2/20 0.48
CACNA1G O43497 1/20 0.47
CACNA1H O95180 1/20 0.47
CACNA1I Q9P0X4 1/20 0.47
SCD O00767 2/20 0.46
PPARD Q03181 2/20 0.45
PPARA Q07869 2/20 0.45
CNR2 P34972 1/20 0.45
PPARG P37231 1/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925363 0.90 ALDH1A1 (0.58) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4923383 0.86 MAPT (0.62) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4918942 0.86 MAPT (0.59) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4923415 0.85 ALDH1A1 (0.71) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4928586 0.85 KMT2A (0.60) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4928386 0.85 MAPT (0.60) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL14184690 0.85 MAPT (0.63) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL14214493 0.85 MAPT (0.62) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4916437 0.84 MAPT (0.62) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL4923403 0.83 MAPT (0.66) KDM4EMAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 KDM4E 1589/4885MAPT 1729/4885MEN1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.